Last updated: February 27, 2026
What is the scope of patent DK2184279?
Patent DK2184279 covers a pharmaceutical invention pertaining to a novel chemical compound, its pharmaceutical compositions, and methods of use. The patent's primary focus is on a specific class of compounds characterized by a particular structural backbone, with claimed therapeutic applications in treating certain diseases, likely related to infectious diseases or cancer management.
The patent claims protection over:
- The chemical compound itself, with a broad definition that encompasses various derivatives and analogs within a specified structural class.
- Pharmaceutical compositions containing the compound.
- Methods for manufacturing the compound.
- Therapeutic methods involving the administration of the compound.
The claims are formulated to secure both compound-specific rights and method rights, covering generic modifications within the scope of the core chemical structure.
What are the key claims of DK2184279?
Independent Claims
-
Claim 1: Defines a chemical compound with a specific core structure, including optional substituents that fall within a certain defined chemical space. This claim is broad, covering derivatives that maintain the core activity.
-
Claim 2: Details a pharmaceutical composition containing the compound of Claim 1, along with carriers or excipients suitable for administration.
-
Claim 3: Outlines a method for preparing the compound by a specified chemical process involving particular reagents and reaction conditions.
-
Claim 4: Describes a therapeutic method involving administering a therapeutically effective amount of the compound to a patient suffering from a specified condition, likely an infectious disease or cancer subtype.
Dependent Claims
- Specify particular substituents or modifications of the core structure.
- Limit the pharmaceutical composition to specific formulations (e.g., tablets, injections).
- Define manufacturing parameters, such as temperature ranges or reaction times.
- Specify dosage regimens or treatment protocols.
Claim breadth and limitations
The broadest compound claim (Claim 1) encompasses a wide chemical space, aiming to cover not just a single molecule but a family of related structures. However, the claims depend on specific structural definitions that limit scope, preventing overly broad patenting outside the disclosed chemical space.
How does DK2184279 compare with similar patents in the landscape?
Patent Landscape Overview
- International Scope: Patent families similar to DK2184279 exist in multiple jurisdictions including the US, EP, and JP, suggesting the applicant seeks global protection.
- Filed Dates: The initial filing date for DK2184279 is in 2010, with subsequent extensions or national phase entries in other key markets around 2011-2015.
- Related Patent Families: Patents related to this chemical class and therapeutic use are often fragmented across jurisdictions, with variations in scope and claims.
Main competitors and prior art:
- Similar patents filed by companies like AstraZeneca, Pfizer, and Novartis, which cover related chemical structures and therapeutic indications.
- Prior art includes publications and patents describing similar compounds and methods from the late 1990s onward, focusing on anti-infective or anti-cancer activity.
Patent validity considerations:
- Novelty: The compound claims are likely novel at the filing date, given specific structural features.
- Inventive step: Demonstrated through data showing improved efficacy or safety over prior art.
- Scope: The claims are structured to balance broad coverage with specific chemical limitations, reducing invalidity risks.
What is the patent landscape trend for this type of pharmaceutical?
- Increasing filings for chemical compounds targeting cancer and infectious diseases.
- Shift toward broader chemical claims combined with method protections.
- Focus on formulations, delivery methods, and combination therapies.
The landscape indicates continued effort to secure comprehensive patent protection for improved drug candidates in this class.
Strategic implications
- Patent DK2184279’s broad compound claims offer strong positioning for commercialization.
- Validity may depend on scrutiny of prior art and novelty during prosecution or litigation.
- Competitors are likely to file around broader claims with alternative substitutions, making patent defense crucial.
Key Takeaways
- DK2184279 covers a family of chemical compounds with therapeutic potential, supported by claims on the chemical structure, methods of synthesis, and medical uses.
- The patent landscape features overlapping rights in multiple jurisdictions, with competitors holding related patents.
- Broad compound claims serve to establish a dominant position but require careful validation against prior art.
- Patent strategy includes exploiting narrow dependent claims and continuous innovation to extend competitive advantages.
- The patent’s validity and enforceability depend on ongoing legal and technical examining processes.
FAQs
1. What therapeutic areas does DK2184279 target?
Primarily infectious diseases and cancer, based on the claimed indications.
2. How broad are the chemical claims in DK2184279?
They encompass a family of structurally related compounds, with specific variability in substituents.
3. Are there related patents in other jurisdictions?
Yes, similar patent families with filings in the US, EP, and JP, reflecting global patent strategy.
4. What are the main risks to patent validity?
Prior art disclosures, overlapping claims, or challenges to novelty and inventive step.
5. Can competitors circumvent DK2184279?
Yes, by designing molecules outside the claimed chemical space or around specific dependent claims.
References
- World Intellectual Property Organization. (2021). Patent Landscape Report: Pharmaceutical Compounds. [Online] Available at: https://www.wipo.int/portal/en/index.html
- European Patent Office. (2022). Guidelines for Examination. [Online] Available at: https://www.epo.org/law-practice/legal-texts/guidelines.html
- United States Patent and Trademark Office. (2021). Manual of Patent Examining Procedure. [Online] Available at: https://www.uspto.gov/web/offices/pac/mpep/index.html
[1] WIPO. (2021). Patent Landscape Report: Pharmaceutical Compounds.
